These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1577745)

  • 1. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
    Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
    J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ehlers-Danlos syndrome type VIIB. Morphology of type I collagen fibrils formed in vivo and in vitro is determined by the conformation of the retained N-propeptide.
    Holmes DF; Watson RB; Steinmann B; Kadler KE
    J Biol Chem; 1993 Jul; 268(21):15758-65. PubMed ID: 8340401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface located procollagen N-propeptides on dermatosparactic collagen fibrils are not cleaved by procollagen N-proteinase and do not inhibit binding of decorin to the fibril surface.
    Watson RB; Holmes DF; Graham HK; Nusgens BV; Kadler KE
    J Mol Biol; 1998 Apr; 278(1):195-204. PubMed ID: 9571043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
    Chiodo AA; Hockey A; Cole WG
    J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of collagen fibrils by enzymic cleavage of precursors of type I collagen in vitro.
    Miyahara M; Hayashi K; Berger J; Tanzawa K; Njieha FK; Trelstad RL; Prockop DJ
    J Biol Chem; 1984 Aug; 259(15):9891-8. PubMed ID: 6430905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
    Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
    J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
    Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
    J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.
    Carr AJ; Chiodo AA; Hilton JM; Chow CW; Hockey A; Cole WG
    J Med Genet; 1994 Apr; 31(4):306-11. PubMed ID: 8071956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.
    Vasan NS; Kuivaniemi H; Vogel BE; Minor RR; Wootton JA; Tromp G; Weksberg R; Prockop DJ
    Am J Hum Genet; 1991 Feb; 48(2):305-17. PubMed ID: 1990839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.
    Steinmann B; Tuderman L; Peltonen L; Martin GR; McKusick VA; Prockop DJ
    J Biol Chem; 1980 Sep; 255(18):8887-93. PubMed ID: 6773953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen.
    Byers PH; Duvic M; Atkinson M; Robinow M; Smith LT; Krane SM; Greally MT; Ludman M; Matalon R; Pauker S; Quanbeck D; Schwarze U
    Am J Med Genet; 1997 Oct; 72(1):94-105. PubMed ID: 9295084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
    Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
    Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant.
    Weil D; Bernard M; Combates N; Wirtz MK; Hollister DW; Steinmann B; Ramirez F
    J Biol Chem; 1988 Jun; 263(18):8561-4. PubMed ID: 2454224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
    Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
    J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
    Chiodo AA; Sillence DO; Cole WG; Bateman JF
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases.
    Miyahara M; Njieha FK; Prockop DJ
    J Biol Chem; 1982 Jul; 257(14):8442-8. PubMed ID: 6806297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.
    Eyre DR; Shapiro FD; Aldridge JF
    J Biol Chem; 1985 Sep; 260(20):11322-9. PubMed ID: 2993307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerization of pNcollagen I and copolymerization of pNcollagen I with collagen I. A kinetic, thermodynamic, and morphologic study.
    Romanic AM; Adachi E; Hojima Y; Engel J; Prockop DJ
    J Biol Chem; 1992 Nov; 267(31):22265-71. PubMed ID: 1331049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.